1) Haddow A: Influence of certain polycyclic hydrocarbons on the growth of the jenson rat sarcoma. Nature 1935; 136: 868-869.
2) Polovich, M., Olsen, MM (eds). Safe Handling of Hazardous Drugs, 3rd ed.; Oncology Nursing Society (ONS): Pennsylvania, United States, 2017, p3-4.
3) The Japanese Society of Medical Oncology, the Japanese Society of Pharmaceutical Oncology and the Japanese Society of Cancer Nursing. The JSCN/JSMO/JASPO Guidelines for Safe Handling of Cancer Chemotherapy Drugs. 1st ed.; Kanehara & Co., Ltd.: Japan, 2015
4) The Japanese Society of Medical Oncology, the Japanese Society of Pharmaceutical Oncology and the Japanese Society of Cancer Nursing. The JSCN/JSMO/JASPO Guidelines for Safe Handling of Cancer Chemotherapy Drugs. 2st ed.; Kanehara & Co., Ltd.: Japan, 2019
5) Centers for Disease Control and Prevention. NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, NIOSH—Publications Dissemination: Cincinnati, OH, 2004, p31-2.
6) USP General Chapter <800>Hazardous drugs –handling in healthcare settings. Reprinted from USP 40—NF 35, Second Supplement, 2017, p2. https://www.usp.org/sites/default/files/usp/document/our-work/healthcare-quality- safety/general-chapter-800.pdf. Downloaded June 20, 2020
7) Centers for Disease Control and Prevention. NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, NIOSH—Publications Dissemination: Cincinnati, OH, 2004, p33.
8) National Institute for Occupational Safety and Health, NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016.https://www.cdc.gov/niosh/docs/2016-61/pdfs/2016-.pdf?id=10.26616/NIOSHPUB2 016161. Downloaded June 20, 2020.
9) Polovich, M., Olsen, MM (eds). Safe Handling of Hazardous Drugs, 3rd ed.; Oncology Nursing Society (ONS): Pennsylvania, United States, 2017, p6-17.
10) National Institute for Occupational Safety and Health (NIOSH). NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings,2004, p3-4.
11) American Society of Health-System Pharmacists (ASHP). ASHP Guidelines on Handling Hazardous Drugs, American Society of Health-System Pharmacists: United States, 2006, p34.
12) Polovich, M., Olsen, MM (eds). Safe Handling of Hazardous Drugs, 3rd ed.; Oncology Nursing Society (ONS): Pennsylvania, United States, 2017, p11-7.
13) International Society of Oncology Pharmacy Practitioners Standards Committee (ISOPP), ISOPP Standards of Practice. Safe Handling of Cytotoxics, J Oncol Pharm Pract, 2007;13 Suppl, 3-4.
14) Occupational Safety and Health Administration (OSHA). IV.E. Work areas.Controlling Occupational Exposure to Hazardous Drugs, 2016.
15) USP General Chapter <800>Hazardous drugs –handling in healthcare settings.2017, p2.
16) The Japanese Society of Medical Oncology, the Japanese Society of Pharmaceutical Oncology and the Japanese Society of Cancer Nursing. The JSCN/JSMO/JASPO Guidelines for Safe Handling of Cancer Chemotherapy Drugs. 2st ed.; Kanehara & Co.,Ltd.: Japan, 2019, p41.
17) U.S. Department of Labor, Recommended Practices for Safety and Health Programs.https://www.osha.gov/shpguidelines/hazard-prevention.html
18) Polovich, M., Olsen, MM (eds). Safe Handling of Hazardous Drugs, 3rd ed.; Oncology Nursing Society (ONS): Pennsylvania, United States, 2017, p18-27.
19) Rudolf Schierl, Autenrieth Herwig, Andreas Pfaller, et al. Surface contamination of antineoplastic drug vials: comparison of unprotected and protected vials. Am J Health Syst Pharm. 2010;67(6):428-9
20) Hama K, Fukushima K, Hirabatake M, et al. Verication of surface contamination of Japanese cyclophosphamide viais and anexample of exposure by handling, J Oncol Pharm Practice,2012;18(2):201-6.
21) 吉田昭昌,高見陽一郎,花田貴恵,他.抗がん薬のバイアル表面汚染に関する検討 ~製薬会社に対するアンケート調査結果も踏まえて~.医療薬学. 2015;41(3):163-72.
22) Centers for Disease Control and Prevention. NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, NIOSH—Publications Dissemination: Cincinnati, OH, 2004, p. 3-4.
23) Polovich, M., Olsen, MM., LeFebvre, KB. Chemotherapy and Biotherapy guidelines and Recommendations for Practice. 4th ed.; Oncology Nursing Society (ONS): Pennsylvania, United States, 2014.
24) Sessink PJ, Kroese ED, van Kranen HJ, et al, Cancer Risk Assessment for Health Care Workers Occupationally Exposed to Cyclophosphamide, Int Arch Occup Environ Health, 1995; 67(5), 317-23.
25) National Institute for Occupational Safety and Health (NIOSH). NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings, NIOSH—Publications Dissemination: Cincinnati, OH, 2004, p18.
26) American Society of Health-System Pharmacists (ASHP). ASHP Guidelines on Handling Hazardous Drugs, American Society of Health-System Pharmacists: UnitedStates, 2006, p80.
27) International Society of Oncology Pharmacy Practitioners Standards Committee (ISOPP), ISOPP Standards of Practice. Safe Handling of Cytotoxics, J Oncol Pharm Pract, 2007;13 Suppl, 62-5.
28) Polovich, M., Olsen, MM. (eds). Safe Handling of Hazardous Drugs, 3rd ed.; Oncology Nursing Society (ONS): Pennsylvania, United States, 2017, p54-8.
29) Occupational Safety and Health Administration (OSHA). V.H. spills. Controlling Occupational Exposure to Hazardous Drugs, 2016. https://www.osha.gov/SLTC/hazardousdrugs/controlling_occex_hazardousdrugs.html. Downloaded June 20, 2020.
30) USP General Chapter <800> Hazardous Drugs –Handling in Healthcare Settings. 2017, p11.https://www.usp.org/sites/default/files/usp/document/our-work/healthcare-quality- safety/general-chapter-800.pdf. Downloaded June 20, 2020.
31) 川本英子,浜原安奈,兼光朝子,他.フルオロウラシル内用薬のPTPシート汚染原因の検討.医療薬学.41(9) 630-635,2015
32) Kobayashi Y, Iwane Y, Nakanishi H, Evaluation of Shatter-Resistance of Surface- Protected Vial (Onco-TainTM Vial) for Preventing Occupational Exposures to Antineoplastic Drugs, J Pharm Health Care Sci, 2014; 40(6), 352-9.
33) The Ministry of Health, Labour and Welfare, G7 Containers and Package Basic Requirements and Terms for the Packaging of Pharmaceutical Products, The Japanese 17th Pharmacopoeia Seventeenth Edition, 2016; G7, 2455-8.
34) Polovich, M., Olsen, MM (eds). Safe Handling of Hazardous Drugs, 3rd ed.; Oncology Nursing Society (ONS): Pennsylvania, United States, 2017, p6-17.